Parenteral–Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B

Chronic hepatitis B (CHB) is the cause of severe liver damage, cirrhosis, and hepatocellular carcinoma for over 240 million people worldwide. Nowadays, several types of treatment are being investigated, including immunotherapy using hepatitis B core antigen (HBcAg) assembled into highly immunogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyrski, Marcin, Mieloch, Adam Aron, Plewiński, Adam, Basińska-Barczak, Aneta, Gryciuk, Aleksandra, Bociąg, Piotr, Murias, Marek, Rybka, Jakub Dalibor, Pniewski, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963566/
https://www.ncbi.nlm.nih.gov/pubmed/31835350
http://dx.doi.org/10.3390/vaccines7040211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963566/
https://www.ncbi.nlm.nih.gov/pubmed/31835350
http://dx.doi.org/10.3390/vaccines7040211

Ejemplares similares